Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Sep;91(9):1213-4.
doi: 10.1136/hrt.2004.035030.

Secondary prevention with folic acid: results of the Goes extension study

Clinical Trial

Secondary prevention with folic acid: results of the Goes extension study

A Liem et al. Heart. 2005 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative event rate according to random allocation to folic acid treatment (dashed line) and control (solid line). Analysis for cumulative event rate for death, acute coronary syndromes (ACS) or cerebrovascular accident (CVA) or transient ischaemic attack. Probability value is estimated by log rank statistic.

References

    1. Wald DS, Law M, Mooris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202–9. - PMC - PubMed
    1. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288:2015–22. - PubMed
    1. Lange H, Suryapranata H, De Luca, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 2004;350:2673–81. - PubMed
    1. Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, et al. Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol 2003;41:2105–13. - PubMed
    1. Trevelyan J, Needham EW, Smith SC. Sources of diagnostic inaccuracy of conventional versus new diagnostic criteria for myocardial infarction in an unselected UK population with suspected cardiac pain, and investigation of independent prognostic variables. Heart 2003;89:1406–10. - PMC - PubMed

Substances